-5%
- Tigel 90 lowers the risk of heart attacks, strokes, and cardiovascular death in patients with a prior history of heart attack or who have blocked arteries.
- It helps prevent the formation of harmful blood clots, especially in patients with coronary artery disease (CAD) who have undergone stent placement.
- Tigel 90 also reduces the risk of a first heart attack or stroke in individuals with reduced blood flow to the heart (stable coronary artery disease).
- It decreases the risk of stroke and death in adults with narrowed or blocked arteries supplying blood to the brain.
- Tigel 90 is usually prescribed along with low-dose aspirin for better prevention of clot-related events.
Ticagrelor is prescribed to reduce the risk of atherothrombotic events in adults with acute coronary syndromes (ACS), including unstable angina, NSTEMI, and STEMI. It is suitable for patients managed medically as well as those undergoing procedures like PCI or CABG.
